Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low Omicron BA.4 and BA.5 neutralising activity and breakthrough COVID-19 following pre-exposure prophylaxis with tixagevimab plus cilgavimab in vaccinated patients with autoimmune disease.
Connolly CM, Karaba AH, Po-Yu Chiang T, Teles M, Kim JD, Scott Johnson T, Alejo JL, Segev DL, Christopher-Stine L, Werbel WA, Paik JJ. Connolly CM, et al. Clin Exp Rheumatol. 2023 May;41(5):1202-1203. doi: 10.55563/clinexprheumatol/pfli7o. Epub 2023 Feb 23. Clin Exp Rheumatol. 2023. PMID: 36826787 Free article. No abstract available.
Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL; OMERACT Connective Tissue Disease–Interstitial Lung Diseases Working Group; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group. Saketkoo LA, et al. J Rheumatol. 2014 Apr;41(4):792-8. doi: 10.3899/jrheum.131251. Epub 2014 Feb 1. J Rheumatol. 2014. PMID: 24488412 Free PMC article. Review.
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Fiorentino D, Mangold AR, Werth VP, Christopher-Stine L, Femia A, Chu M, Musiek ACM, Sluzevich JC, Graham LV, Fernandez AP, Aggarwal R, Rieger K, Page KM, Li X, Hyde C, Rath N, Sloan A, Oemar B, Banerjee A, Salganik M, Banfield C, Neelakantan S, Beebe JS, Vincent MS, Peeva E, Vleugels RA. Fiorentino D, et al. Among authors: christopher stine l. Lancet. 2025 Jan 11;405(10473):137-146. doi: 10.1016/S0140-6736(24)02071-3. Lancet. 2025. PMID: 39798982 Clinical Trial.
Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy.
Tiniakou E, Girgis A, Siafei T, Albayda J, Adler B, Paik JJ, Mecoli CA, Rebman A, Soloski MJ, Christopher-Stine L, Smith KN, Rosen A, Mammen AL, Darrah E. Tiniakou E, et al. Among authors: christopher stine l. Ann Rheum Dis. 2024 Oct 11:ard-2024-225732. doi: 10.1136/ard-2024-225732. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39393845
The Relationship Between Anti-Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti-Sp4 Autoantibodies, and Cancer in Anti-Transcription Intermediary Factor 1γ-Positive Dermatomyositis.
Mecoli CA, Fiorentino D, Albayda J, Paik JJ, Tiniakou E, Adler B, Mammen AL, Christopher-Stine L, Rosen A, Casciola-Rosen L. Mecoli CA, et al. Among authors: christopher stine l. ACR Open Rheumatol. 2024 Dec;6(12):912-917. doi: 10.1002/acr2.11750. Epub 2024 Oct 6. ACR Open Rheumatol. 2024. PMID: 39370373 Free PMC article.
Telemedicine for the Care of Patients with Idiopathic Inflammatory Myopathies: Experience, Insights and Future Directions from the International Myositis Assessment and Clinical Studies Telemedicine Scientific Interest Group.
Day J, Kushlaf H, Tarvin S, Cavagna L, Codullo V, Shinjo SK, Lyu X, Knitza J, Hajji R, Blier PR, Tseng CW, Appenzeller S, Rider LG, Christopher-Stine L, Gupta L; International Myositis Assessment and Clinical Studies (IMACS) Telemedicine Scientific Interest Group. Day J, et al. Among authors: christopher stine l. Curr Rheumatol Rep. 2024 Dec;26(12):414-420. doi: 10.1007/s11926-024-01163-8. Epub 2024 Aug 31. Curr Rheumatol Rep. 2024. PMID: 39215900 No abstract available.
Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group.
Romich E, Saygin D, DiRenzo D, Mecoli CA, de Groot I, Lodin K, Regardt M, Sarver C, Kim JY, Park JK, Beer K, Needham M, Alexanderson H, Christopher-Stine L, de Visser M, Raaphorst J; OMERACT Myositis Working Group. Romich E, et al. Among authors: christopher stine l. Semin Arthritis Rheum. 2024 Oct;68:152534. doi: 10.1016/j.semarthrit.2024.152534. Epub 2024 Aug 10. Semin Arthritis Rheum. 2024. PMID: 39159576
204 results